Target intelligence / Profile preview

Mitogen-activated protein kinase kinase kinase 12 (MAP3K12)

Target
MAP3K12
Molecular classification
Enzyme (Protein kinase), Serine/threonine protein kinase, Member of the mitogen-activated protein kinase kinase kinase family (MAP3K), LZK subfamily
01

Overview

Mitogen-activated protein kinase kinase kinase 12 (MAP3K12), also known as Dual leucine zipper kinase (DLK), is a serine/threonine-protein kinase predominantly expressed in neurons. It is a critical upstream regulator of kinase cascades that mediate responses to cellular stress, axonal injury, and neuronal development. MAP3K12 activates the MAPK/JNK pathway by phosphorylating and activating MKK7, leading to downstream activation of c-Jun and other transcription factors, ultimately regulating processes such as axon growth, neuronal migration, apoptosis, and axonal degeneration. DLK plays key roles in nervous system development, injury responses, neurodegeneration, and regeneration, and is considered an emerging therapeutic target for neurodegenerative disorders. Selective inhibition of MAP3K12/DLK is neuroprotective in experimental models, but safety concerns remain due to its roles in normal neuronal function and development.

Other names
Dual leucine zipper kinase (DLK)MEKK12MUKZPKZPKP1Leucine-zipper protein kinaseMAPK-upstream kinaseMixed lineage kinasedual leucine zipper bearing kinaseprotein kinase MUK
02

Mechanism of action

Inhibition of MAP3K12/DLK reduces phosphorylation of MKK7 and JNK, blocking pro-apoptotic and degenerative signaling in neurons, thereby providing neuroprotection

03

Biological functions

Signal transductionRegulation of neuronal differentiationNeuronal development (axon growth, neuronal migration)Apoptosis (programmed cell death)Axonal injury response/regenerationActivation of JNK (c-Jun N-terminal kinase) pathwayStress response in neurons
04

Disease associations

Neurodegenerative diseases (e.g., Alzheimer's disease, retinal ganglion cell death)Developmental neuronal disordersPotential roles in psychiatric disorders (e.g., Dependent Personality Disorder, Histrionic Personality Disorder)Other (axon degeneration, neuronal apoptosis)
05

Safety considerations

MAP3K12/DLK is essential for neuronal development and regenerative responses, suggesting that broad inhibition could potentially disrupt neuronal plasticity or developmentPossible off-target effects or interference with adaptive neuronal stress responses
06

Interacting drugs

No specific FDA-approved drugs listed; several small-molecule inhibitors are under investigation preclinically as neuroprotective agents targeting DLK/MAP3K12 in neurodegenerative disease contexts
07

Biomarkers

Phosphorylation status of JNK, c-Jun, and related MAPK pathway proteins may be used as biomarkers in research settings; no validated clinical biomarkers for this target currently

Beyond the preview

Go deeper on Mitogen-activated protein kinase kinase kinase 12 (MAP3K12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 12 (MAP3K12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call